Offer - Urjas Oil for just ₹ 1 X
Aggrilek(Aus) is a commercial drug that is prescribed in the form of Infusion. Primarily, it is used for the treatment of Angina. Aggrilek(Aus) also has some secondary and off-label uses. These are listed below.
The correct dosage of Aggrilek(Aus) depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Some other side effects of Aggrilek(Aus) have been listed ahead. These side effects of Aggrilek(Aus) are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Aggrilek(Aus)'s effect is Unknown during pregnancy and Unknown for lactating mothers. Further, the section on Aggrilek(Aus) related warnings talks about Aggrilek(Aus)'s effects on the liver, heart and kidney.
Aggrilek(Aus) is contraindicated in people with pre-existing medical conditions like Bleeding, Arteriovenous Malformation, Kidney Disease as it can result in adverse effects.
Additionally, Aggrilek(Aus) may also adversely react with other medicines. See below for a complete list.
You should also be aware that Aggrilek(Aus) is safe while driving, and is addiction.
Aggrilek(Aus) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Aggrilek(Aus) safe for pregnant women?
No research has been done to ascertain the safety of Aggrilek(Aus) in pregnant women. If you are pregnant, it is best to ask a doctor to know if you can take it.
Is the use of Aggrilek(Aus) safe during breastfeeding?
No research work has been carried out till date on effect of Aggrilek(Aus) on breastfeeding women. So it is not known whether taking Aggrilek(Aus) will cause side effects or not.
What is the effect of Aggrilek(Aus) on the Kidneys?
Aggrilek(Aus) may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Aggrilek(Aus) on the Liver?
Aggrilek(Aus) has very mild side effects on the liver.
What is the effect of Aggrilek(Aus) on the Heart?
Side effects of Aggrilek(Aus) rarely affect the heart.
Aggrilek(Aus) should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Aggrilek(Aus) unless your doctor advises you to do so -
Is this Aggrilek(Aus) habit forming or addictive?
No, you will not get addicted to Aggrilek(Aus).
Is it safe to drive or operate heavy machinery when consuming?
Aggrilek(Aus) does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Yes, but take Aggrilek(Aus) only as per medical advice.
Is it able to treat mental disorders?
No, the use of Aggrilek(Aus) in mental disorders is not effective.
Interaction between Food and Aggrilek(Aus)
Due to the absence of research, it is difficult to say how Aggrilek(Aus) and food will interact.
Interaction between Alcohol and Aggrilek(Aus)
Information about the interaction of Aggrilek(Aus) and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Aggrastat* (tirofiban hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 631-633
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1208-1210